Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07526584 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparing the Effects of Front-of-Package Labeling Schemes in Indonesia

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 1191 participants (planned 1000) · Primary and study completion dates changed from estimate of Aug 2026 to Sep 18, 2026 · Eligibility criteria expanded, about 8 words · 2 more Show 5 more changesShow less
    • Final enrollment: 1191 participants (planned 1000)
    • Primary and study completion dates changed from estimate of Aug 2026 to Sep 18, 2026
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 4 of 4 entries
    • Site details revised
  2. Recruitment opened Start date changed from estimate of Jul 2026 to Aug 1, 2026 · Site details revisedv4 Show 2 more changesShow less
    • Start date changed from estimate of Jul 2026 to Aug 1, 2026
    • Site details revised
  3. Primary endpoint(s) modified Secondary endpoints: 7 to 4v3 Show 1 more changeShow less
    • Secondary endpoints: 7 to 4

    See this version in full on ClinicalTrials.gov ↗

  4. Start date: Apr 2026 to Jul 2026 Primary and study completion pushed from May 2026 to Aug 2026 · Site contact updatedv2 Show 2 more changesShow less
    • Primary and study completion pushed from May 2026 to Aug 2026
    • Site contact updated
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to examine what type of front-of-package label (FOPL) would be most effective at discouraging consumption of products high in nutrients of concern in Indonesia. The main questions this experiment aims to answer are: 1. Would nutrient warning labels be more effective at discouraging consumption of products high in nutrients of concern compared to the Nutri-Level label? 2. Would nutrient warning labels improve consumers' ability to identify unhealthy products compared to the Nutri-Level label? Additionally, this experiment also aims to determine how should nutrient warning labels be designed to most effectively discourage consumption of products high in nutrients of concern among Indonesian consumers.
Trial Details
NCT Number NCT07526584
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: Bloomberg Philanthropies
Conditions Nutrition, Obesity & Overweight
Enrollment 1,191 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov